Delcath Systems, Inc. (DCTH)
NASDAQ: DCTH · Real-Time Price · USD
10.62
-0.13 (-1.21%)
At close: Aug 1, 2025, 4:00 PM
10.59
-0.03 (-0.28%)
After-hours: Aug 1, 2025, 4:10 PM EDT
DFS Market Cap
Delcath Systems has a market cap or net worth of $360.31 million as of August 1, 2025. Its market cap has increased by 62.89% in one year.
Market Cap
360.31M
Enterprise Value
301.41M
1-Year Change
62.89%
Ranking
Category
Stock Price
$10.62
Market Cap Chart
Since May 10, 2018, Delcath Systems's market cap has increased from $2.70M to $360.31M, an increase of 13,244.70%. That is a compound annual growth rate of 96.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2025 | 380.70M | -1.12% |
| Dec 31, 2024 | 385.00M | 319.85% |
| Dec 29, 2023 | 91.70M | 195.81% |
| Dec 30, 2022 | 31.00M | -45.61% |
| Dec 31, 2021 | 57.00M | -22.76% |
| Dec 31, 2020 | 73.80M | 9,125.00% |
| Dec 31, 2019 | 800.00K | -68.00% |
| Dec 31, 2018 | 2.50M | -7.41% |
| May 10, 2018 | 2.70M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.93B |
| Johnson & Johnson | 404.87B |
| AbbVie | 337.77B |
| Novo Nordisk | 238.11B |
| UnitedHealth Group | 236.83B |
| AstraZeneca | 230.79B |
| Novartis AG | 227.32B |
| Abbott Laboratories | 222.72B |